Structure Therapeutics Inc.
(NASDAQ: GPCR)
|
5:00 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $37.45 | Change: -1.28 | %Change: -3.30% | Volume: 377,298 |
Open: | $ 38.61 | Volume: | 377,298 | |
---|---|---|---|---|
High: | $ 39.30 | Yield(%) | 0.00 | |
Low: | $ 37.38 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 2.21B | |
EPS ($) | -2.31 | Shares Out: | 57.05M |
% Price Change (last 4 weeks): | -28.66 |
---|---|
% Price Change (last 13 weeks): | -2.00 |
% Price Change (last 26 weeks): | -4.11 |
% Price Change (last 52 weeks): | -6.90 |
% Price Change (year to date): | -4.98 |
Return on Equity (%): | -33.30 |
---|---|
Return on Assets (%): | -30.88 |
Return on Invested Capital (%): | -48.59 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | 0.00 |
|
|
50-day Moving Average: | $41.47 |
---|---|
200-day Moving Average: | $46.23 |
Avg. Daily Vol. (last 50 days): | 1,155,538 |
Avg. Daily Vol. (last 200 days): | 945,226 |
52-wk high: | $75.02 |
52-wk low: | $25.57 |
Bid: | $37.48 |
Ask: | $38.35 |
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.
|
Structure Therapeutics Inc.
601 Gateway Boulevard Suite 900 South San Francisco CA 94080 Phone: 1.650.457.1978 Fax: n/a http://www.structuretx.com |
Earnings (1year) ($): | -2.31 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 9.76 |
Cash Flow ($): | -1.91 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | 4.18 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 19.14 |
---|---|
Current Ratio (x): | 19.14 |
LT Debt/Equity (x): | 0.89 |
Total Debt/Equity (x): | 1.20 |